News & Perspective

Nov 17, 2004

Nov 17, 2004

Clinical trials of human H5N1 flu vaccine to start soon

(CIDRAP News) – Clinical trials of a vaccine designed to keep the H5N1 avian influenza virus from sparking a human flu pandemic will begin early in 2005, the head of the National Institute of Allergy and Infectious Diseases (NIAID) said this week.

Mar 25, 2005

Mar 25, 2005

Two studies boost hopes for pandemic flu vaccines

(CIDRAP News) – Two new studies give reason to hope that vaccines prepared in advance could be of some help in combating an influenza pandemic.

Jun 28, 2005

Jun 28, 2005

US must improve pandemic preparedness, group warns

(CIDRAP News) – Pandemic influenza could kill 540,000 Americans and sicken up to 66.9 million, according to a recent report by the nonprofit organization Trust for America's Health (TFAH).

Nov 21, 2006

Nov 21, 2006

Study finds 2 mutations that help H5N1 infect humans

(CIDRAP News) – Researchers recently reported identifying two mutations in the H5N1 avian influenza virus that seem to improve its ability to attach to human cells, a finding that may help scientists spot H5N1 strains capable of infecting humans.

May 02, 2007

May 02, 2007

GAO says financial markets not ready for a pandemic

(CIDRAP News) – A new report from Congress' Government Accountability Office (GAO) says key organizations that are the backbone of the US financial industry need to do more to prepare for an influenza pandemic and urges federal regulators to set deadlines for them to complete pandemic plans.

Jun 19, 2007

Jun 19, 2007

FLU CONFERENCE COVERAGE Virus ownership claims could disrupt flu vaccine system

– TORONTO (CIDRAP News) – The continuing debate over developing countries' ability to afford pandemic-influenza vaccines has produced a disturbing complication: the possibility that Indonesia and other countries affected by H5N1 avian flu will assert legal ownership of the viral isolates on which the vaccines would be based.

Oct 26, 2007

Oct 26, 2007

THE PANDEMIC VACCINE PUZZLE Part 2: Vaccine production capacity falls far short

Editor's note: This is the second in a seven-part series investigating the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. The series puts promising advances in vaccine technology in perspective by illuminating the formidable barriers to producing large amounts of an effective and widely usable vaccine in a short time frame.

Oct 31, 2007

Oct 31, 2007

THE PANDEMIC VACCINE PUZZLE Part 5: What role for prepandemic vaccination?

Editor's note: This is the fifth in a seven-part series investigating the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. The series puts promising advances in vaccine technology in perspective by illuminating the formidable barriers to producing large amounts of an effective and widely usable vaccine in a short time frame.

Nov 15, 2007

Nov 15, 2007

THE PANDEMIC VACCINE PUZZLE Can we vaccinate enough people in time to matter?

Maryn McKennaContributing Writer

(CIDRAP News) – This in-depth article investigates the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. Its seven parts put advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.

Jan 23, 2008

Jan 23, 2008

GAO cites barriers to antiviral, vaccine roles in pandemic

(CIDRAP News) – Antiviral medications and vaccines are two tools that many government and health officials hope will stall the spread of an influenza pandemic, but each strategy has daunting challenges, according to a new report from Congress's Government Accountability Office (GAO).

Pages

by country

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Unorthodox Philanthropy logo and text 'Leading Underwriter'3M logoGilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»